April 2021 PMID 32362898

Human Immune Responses to Adeno-Associated Virus (AAV) Vectors.

Giuseppe Ronzitti, David-Alexandre Gross, Federico Mingozzi

Mentions

22
Peak: 5 in Mar 2023
across 4 sources since May 2020

Extended reach

333,506
potential audience

Total likes

21

Video views

249

Mentions per month

May 2020 – May 2023

Where it's discussed

  • News10 articles
  • X / Twitter7 posts
  • Blogs3 articles
  • YouTube2 videos

AI synopsis

What people are saying

The discussions reflect a balanced recognition of the article's importance, with statements like 'rAAV vectors can trigger both innate and adaptive immune responses,' showing the relevance of immune responses in gene transfer. The tone is analytical and emphasizes the challenges in translating preclinical models to humans, underscoring the impact of the research on future therapies.

AgreementModerate agreement

Most discussions acknowledge that preclinical models don't fully predict human immune responses, showing a moderate consensus on the article's findings.

InterestModerate interest

Participants express a moderate level of curiosity about how immune responses affect gene therapy, indicating engagement but not overwhelming enthusiasm.

EngagementModerate engagement

The posts reference specific aspects like innate and adaptive immunity and mention the research by Ronzitti et al., demonstrating a basic but meaningful level of engagement.

ImpactModerate impact

The discussions highlight that understanding immune responses is crucial for advancing gene therapy, suggesting a recognition of their significance.

Abstract in brief

  • Recombinant adeno-associated virus (rAAV) vectors are promising tools for gene delivery due to their efficiency, but their high similarity to wildtype viruses that infect humans can lead to immune responses that limit their effectiveness.
  • Both humoral (antibody-mediated) and cell-mediated immune responses to wildtype AAV are observed in healthy donors, and anti-AAV antibodies can significantly affect gene transfer outcomes.
  • Factors like vector design and dosage influence the immune response, with current research indicating that rAAV vectors can trigger both innate and adaptive immunity, presenting challenges and opportunities for improving gene therapy strategies.]

Top posts

Most liked on X and Bluesky
Dr Dave Cartland BMedSc MBChB Ex-MRCGP
@CartlandDavid · X

https://t.co/Z587MjE3mT “While preclinical models have been less than ideal in predicting the outcome of gene transfer in humans, the current preclinical body of evidence clearly demonstrates that rAAV vectors can trigger both innate and adaptive immune responses.”

Mar 28, 2023 · 12 likes · 5 shares · 307,581 followers View post →
flosz
@floszcrxl · X

Human Immune Responses to Adeno-Associated Virus (AAV) Vectors https://t.co/IVh5dNGFCv

May 5, 2020 · 1 like · 709 followers View post →
Mike Stock
@mikestockmusic · X

RT @CartlandDavid: https://t.co/Z587MjE3mT “While preclinical models have been less than ideal in predicting the outcome of gene transfer i…

Mar 28, 2023 · 5 shares · 18,385 followers View post →
EWN ✝️ ️In God I trust
@ewn1047 · X

RT @CartlandDavid: https://t.co/Z587MjE3mT “While preclinical models have been less than ideal in predicting the outcome of gene transfer i…

Mar 29, 2023 · 5 shares · 3,525 followers View post →
Evie *****
@Evie707656912 · X

RT @CartlandDavid: https://t.co/Z587MjE3mT “While preclinical models have been less than ideal in predicting the outcome of gene transfer i…

Mar 28, 2023 · 5 shares · 2,774 followers View post →
the paper link
@the_paper_link · X

Trend new: *Ronzitti G* et al (Front Immunol) __Human Immune Responses to Adeno-Associated Virus (AAV) Vectors__ https://t.co/FhUojmC2cE

May 6, 2020 · 137 followers View post →

All mentions

Adeno-Associated Virus and CRISPR-Cas9 in Gene Therapy

Recombinant adeno-associated virus vectors are promising tools for gene delivery, but their similarity to wildtype viruses can trigger immune responses. These responses may affect gene therapy effectiveness, influenced…

Mak KH · May 7, 2022 105 views
EWN ✝️ ️In God I trust
@ewn1047 · X

RT @CartlandDavid: https://t.co/Z587MjE3mT “While preclinical models have been less than ideal in predicting the outcome of gene transfer i…

Mar 29, 2023 · 5 shares · 3,525 followers View post →
Mike Stock
@mikestockmusic · X

RT @CartlandDavid: https://t.co/Z587MjE3mT “While preclinical models have been less than ideal in predicting the outcome of gene transfer i…

Mar 28, 2023 · 5 shares · 18,385 followers View post →
Evie *****
@Evie707656912 · X

RT @CartlandDavid: https://t.co/Z587MjE3mT “While preclinical models have been less than ideal in predicting the outcome of gene transfer i…

Mar 28, 2023 · 5 shares · 2,774 followers View post →
whoisthatchild2
@whoisthatchild2 · X

RT @CartlandDavid: https://t.co/Z587MjE3mT “While preclinical models have been less than ideal in predicting the outcome of gene transfer i…

Mar 28, 2023 · 5 shares · 96 followers View post →
Dr Dave Cartland BMedSc MBChB Ex-MRCGP
@CartlandDavid · X

https://t.co/Z587MjE3mT “While preclinical models have been less than ideal in predicting the outcome of gene transfer in humans, the current preclinical body of evidence clearly demonstrates that rAAV vectors can trigger both innate and adaptive immune responses.”

Mar 28, 2023 · 12 likes · 5 shares · 307,581 followers View post →
the paper link
@the_paper_link · X

Trend new: *Ronzitti G* et al (Front Immunol) __Human Immune Responses to Adeno-Associated Virus (AAV) Vectors__ https://t.co/FhUojmC2cE

May 6, 2020 · 137 followers View post →
flosz
@floszcrxl · X

Human Immune Responses to Adeno-Associated Virus (AAV) Vectors https://t.co/IVh5dNGFCv

May 5, 2020 · 1 like · 709 followers View post →